These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 15265677)

  • 1. Changes of matrix metalloproteinase-9 and its tissue inhibitor (TIMP-1) after autologous hematopoietic stem cell transplantation in multiple sclerosis.
    Blanco Y; Saiz A; Carreras E; Graus F
    J Neuroimmunol; 2004 Aug; 153(1-2):190-4. PubMed ID: 15265677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple sclerosis: elevated expression of matrix metalloproteinases in blood monocytes.
    Kouwenhoven M; Ozenci V; Gomes A; Yarilin D; Giedraitis V; Press R; Link H
    J Autoimmun; 2001 Jun; 16(4):463-70. PubMed ID: 11437495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased acinar damage of salivary glands of patients with Sjögren's syndrome is paralleled by simultaneous imbalance of matrix metalloproteinase 3/tissue inhibitor of metalloproteinases 1 and matrix metalloproteinase 9/tissue inhibitor of metalloproteinases 1 ratios.
    Pérez P; Kwon YJ; Alliende C; Leyton L; Aguilera S; Molina C; Labra C; Julio M; Leyton C; González MJ
    Arthritis Rheum; 2005 Sep; 52(9):2751-60. PubMed ID: 16142742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of mRNA of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase after cardiopulmonary resuscitation for asphyxial cardiac arrest in rat].
    Li ZP; Chen SQ; Wang SS; Huang WJ; Cheng JY; Wang W; Wang WT; Tan YX
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Sep; 17(9):548-51. PubMed ID: 16146602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in patients with relapsing-remitting multiple sclerosis treated with interferon beta.
    Boz C; Ozmenoglu M; Velioglu S; Kilinc K; Orem A; Alioglu Z; Altunayoglu V
    Clin Neurol Neurosurg; 2006 Feb; 108(2):124-8. PubMed ID: 16412833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monocyte matrix and ADAM metalloproteinase expression in type 2 diabetes after aspirin therapy.
    Sampson M; Wall S; Baugh M; Worley J; Davies I; Hughes D; Gavrilovic J
    Diabetes Res Clin Pract; 2006 Jan; 71(1):45-51. PubMed ID: 16023759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent.
    Gouyer V; Conti M; Devos P; Zerimech F; Copin MC; Créme E; Wurtz A; Porte H; Huet G
    Cancer; 2005 Apr; 103(8):1676-84. PubMed ID: 15754326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of interferon beta-1a on serum matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in relapsing remitting multiple sclerosis patients. One year follow-up results.
    Karabudak R; Kurne A; Guc D; Sengelen M; Canpinar H; Kansu E
    J Neurol; 2004 Mar; 251(3):279-83. PubMed ID: 15015006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of angiotensin II receptor blocker on glucose-induced mRNA expressions of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in rat mesangial cells.
    Ding HL; Guo Y; Xu MT; Li HY; Fu ZZ
    Chin Med J (Engl); 2007 Nov; 120(21):1886-9. PubMed ID: 18067760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of matrix metalloproteinases and their inhibitors by interferon-beta: a longitudinal study in multiple sclerosis patients.
    Bernal F; Elias B; Hartung HP; Kieseier BC
    Mult Scler; 2009 Jun; 15(6):721-7. PubMed ID: 19383643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
    Hu XX; Li L; Li DR; Zhang W; Cheng XQ; Zhang JQ; Tang BJ
    Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of matrix metalloproteinase-2, -9 and their inhibitor-1 in hypertrophic scars].
    Xie XF; He LX; Hao XF; Chen B; Jia CY; Sun ZG; Cao YJ; Li DH
    Zhonghua Shao Shang Za Zhi; 2007 Dec; 23(6):444-6. PubMed ID: 18457258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases by Porphyromonas gingivalis in an engineered human oral mucosa model.
    Andrian E; Mostefaoui Y; Rouabhia M; Grenier D
    J Cell Physiol; 2007 Apr; 211(1):56-62. PubMed ID: 17226791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influence of recombinant transforming growth factor-beta3 on collagen synthesis and deposition: experiment with rat cell model of liver fibrosis].
    Li Q; Zhou X; Yu J; Qian W; Xu KS
    Zhonghua Yi Xue Za Zhi; 2008 May; 88(18):1273-8. PubMed ID: 18844103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of mRNAs encoding MMP-9 and MMP-2, and their inhibitors TIMP-1 and TIMP-2 by androgens in the rat ventral prostate.
    Limaye AM; Desai KV; Chavalmane AK; Kondaiah P
    Mol Cell Endocrinol; 2008 Nov; 294(1-2):10-8. PubMed ID: 18675881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of brain-derived neurotrophic factor levels after autologous hematopietic stem cell transplantation in multiple sclerosis.
    Blanco Y; Saiz A; Costa M; Torres-Peraza JF; Carreras E; Alberch J; Jaraquemada D; Graus F
    Neurosci Lett; 2005 May 20-27; 380(1-2):122-6. PubMed ID: 15854763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preliminary assessment of immune reconstitution after autologous peripheral hematopoietic stem cell transplantation (AHSCT)].
    Huang HQ; Cai QC; Shi YX; Lin XB; Wei J; Guo Y; Pan ZH
    Ai Zheng; 2006 Aug; 25(8):1023-8. PubMed ID: 16965687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of a high activity of matrix metalloproteinase-9 to low levels of tissue inhibitors of metalloproteinase-1 and -3 in human hepatitis B-viral hepatoma cells.
    Kim JR; Kim CH
    Int J Biochem Cell Biol; 2004 Nov; 36(11):2293-306. PubMed ID: 15313474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of tissue inhibitor of matrix metalloproteinase-1 in aging of transgenic mouse liver.
    Zhang YM; Chen XM; Wu D; Zhang XG; Lü Y; Shi SZ; Yin Z
    Chin Med J (Engl); 2006 Mar; 119(6):504-9. PubMed ID: 16584649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
    Chen RQ; Chen XM; Cui SW; Cai GY; Shi SZ; Xie YS; Lu Y; Peng LX
    Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):937-42. PubMed ID: 15329283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.